Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Cazin

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Pharmacy World & Science : PWS|September 14, 1999
Implementing a multiple-isolator unit for centralized preparation of cytotoxic drugs in a cancer center pharmacyJ L Cazin, P Gosselin
Pathologie-Biologie|November 1, 1993
[Lymphocyte hybridization and cancerology: diagnostic and therapeutic applications. Example of tumor markers]J L Cazin, P Gosselin, A Demaille
Revue Francaise De Gynecologie Et D'Obstetrique|July 1, 1988
[The place of tumor markers in breast and gynecologic neoplasms]P Gosselin, J L Cazin, M C Demaille, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Drug resistance in oncology: from concepts to applicationsJ L Cazin, P Gosselin, P Cappelaere, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Clinical pharmacokinetics of 6-hour infusion of high-dose methotrexate. Preliminary trial of monitoring high infusion dosesM Luyckx, J L Cazin, C Brunet, et al.
American Journal of Clinical Oncology|January 1, 1988
Significance of PSA and PAP in patients with or without prostatic cancerA Caty, P Gosselin, J L Cazin, et al.
Anticancer Research|May 1, 1992
An evaluation of CA 549, a circulating marker of breast cancer using a procedure for comparison with CA 15.3J L Cazin, P Gosselin, B Boniface, et al.
Biomedical Chromatography : BMC|January 1, 1990
Rapid quantitative determination of epirubicin and its metabolites in plasma using high performance liquid chromatography and fluorescence detectionT Dine, C Brunet, M Luyckx, et al.
Pathologie-Biologie|February 1, 1990
Thyrotropin binding inhibitory immunoglobulin (TBII) and thyroid diseases using ROC analysisC Sulman, P Gosselin, J L Cazin, et al.
Presse Medicale (Paris, France : 1983)|October 17, 1987
[Value of the assay of squamous cell carcinoma in cancer of the uterine cervix]P Gosselin, J L Cazin, J P Dehaut, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Pharmacy World & Science : PWS|September 14, 1999
Implementing a multiple-isolator unit for centralized preparation of cytotoxic drugs in a cancer center pharmacyJ L Cazin, P Gosselin
Pathologie-Biologie|November 1, 1993
[Lymphocyte hybridization and cancerology: diagnostic and therapeutic applications. Example of tumor markers]J L Cazin, P Gosselin, A Demaille
Revue Francaise De Gynecologie Et D'Obstetrique|July 1, 1988
[The place of tumor markers in breast and gynecologic neoplasms]P Gosselin, J L Cazin, M C Demaille, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Drug resistance in oncology: from concepts to applicationsJ L Cazin, P Gosselin, P Cappelaere, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Clinical pharmacokinetics of 6-hour infusion of high-dose methotrexate. Preliminary trial of monitoring high infusion dosesM Luyckx, J L Cazin, C Brunet, et al.
American Journal of Clinical Oncology|January 1, 1988
Significance of PSA and PAP in patients with or without prostatic cancerA Caty, P Gosselin, J L Cazin, et al.
Anticancer Research|May 1, 1992
An evaluation of CA 549, a circulating marker of breast cancer using a procedure for comparison with CA 15.3J L Cazin, P Gosselin, B Boniface, et al.
Biomedical Chromatography : BMC|January 1, 1990
Rapid quantitative determination of epirubicin and its metabolites in plasma using high performance liquid chromatography and fluorescence detectionT Dine, C Brunet, M Luyckx, et al.
Pathologie-Biologie|February 1, 1990
Thyrotropin binding inhibitory immunoglobulin (TBII) and thyroid diseases using ROC analysisC Sulman, P Gosselin, J L Cazin, et al.
Presse Medicale (Paris, France : 1983)|October 17, 1987
[Value of the assay of squamous cell carcinoma in cancer of the uterine cervix]P Gosselin, J L Cazin, J P Dehaut, et al.
Pageof 2